Group One Trading
IRWD icon

Group One Trading’s Ironwood Pharmaceuticals IRWD Stock Holding History

Group One Trading’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$305K Buy
87,000
+77,800
+846% +$319K ﹤0.01% 3784
2025
Q4 		$31K Buy
9,200
+5,300
+136% +$13.8K ﹤0.01% 5994
2025
Q3 		$5.11K Buy
+3,900
New +$4.04K ﹤0.01% 7534
2025
Q1 		– Sell
-1,800
Closed -$7.97K – 7956
2024
Q4 		$7.97K Sell
1,800
-200
-10% -$811 ﹤0.01% 6209
2024
Q3 		$8.24K Buy
+2,000
New +$10.8K ﹤0.01% 5693
2024
Q2 		– Sell
-136,800
Closed -$1.19M – 7091
2024
Q1 		$1.19M Buy
136,800
+127,400
+1,355% +$1.55M ﹤0.01% 1929
2023
Q4 		$108K Buy
+9,400
New +$93K ﹤0.01% 4404
2022
Q3 		– Sell
-100
Closed -$1K – 7849
2022
Q2 		$1K Sell
100
-1,100
-92% -$13K ﹤0.01% 7557
2022
Q1 		$15K Sell
1,200
-4,400
-79% -$50.4K ﹤0.01% 6948
2021
Q4 		$65K Sell
5,600
-3,600
-39% -$44.2K ﹤0.01% 6111
2021
Q3 		$120K Sell
9,200
-2,900
-24% -$37.5K ﹤0.01% 5728
2021
Q2 		$156K Sell
12,100
-11,700
-49% -$134K ﹤0.01% 5499
2021
Q1 		$266K Buy
+23,800
New +$251K ﹤0.01% 4714
2020
Q4 		– Sell
-7,000
Closed -$63K – 6728
2020
Q3 		$63K Buy
7,000
+4,000
+133% +$39.8K ﹤0.01% 4494
2020
Q2 		$31K Buy
+3,000
New +$30.7K ﹤0.01% 4622
2020
Q1 		– Sell
-500
Closed -$7K – 5494
2019
Q4 		$7K Sell
500
-300
-38% -$3.31K ﹤0.01% 4685
2019
Q3 		$7K Hold
800
– – ﹤0.01% 4679
2019
Q2 		$9K Sell
800
-8,991
-92% -$101K ﹤0.01% 4455
2019
Q1 		$111K Sell
9,791
-7,283
-43% -$81.3K ﹤0.01% 3103
2018
Q4 		$148K Sell
17,074
-836
-5% -$9.59K ﹤0.01% 2904
2018
Q3 		$277K Buy
17,910
+239
+1% +$3.78K ﹤0.01% 2766
2018
Q2 		$283K Buy
17,671
+15,164
+605% +$224K ﹤0.01% 2766
2018
Q1 		$32K Sell
2,507
-2,627
-51% -$32.7K ﹤0.01% 3874
2017
Q4 		$64K Sell
5,134
-19,104
-79% -$250K ﹤0.01% 3596
2017
Q3 		$320K Sell
24,238
-27,343
-53% -$376K ﹤0.01% 2411
2017
Q2 		$816K Sell
51,581
-19,462
-27% -$283K 0.01% 1614
2017
Q1 		$1.01M Buy
71,043
+26,268
+59% +$359K 0.01% 1332
2016
Q4 		$573K Sell
44,775
-105,311
-70% -$1.33M 0.01% 1673
2016
Q3 		$2M Sell
150,086
-61,133
-29% -$715K 0.02% 853
2016
Q2 		$2.31M Buy
211,219
+208,473
+7,592% +$2.04M 0.03% 738
2016
Q1 		$25K Sell
2,746
-9,672
-78% -$79.8K ﹤0.01% 3633
2015
Q4 		$121K Sell
12,418
-89,550
-88% -$865K ﹤0.01% 2862
2015
Q3 		$890K Buy
101,968
+9,433
+10% +$88K 0.01% 1334
2015
Q2 		$935K Buy
92,535
+87,520
+1,745% +$1.02M 0.01% 1263
2015
Q1 		$67K Sell
5,015
-23,402
-82% -$307K ﹤0.01% 3171
2014
Q4 		$365K Sell
28,417
-5,970
-17% -$68.3K 0.01% 1801
2014
Q3 		$373K Sell
34,387
-58,864
-63% -$674K 0.01% 1836
2014
Q2 		$1.2M Sell
93,251
-1,314
-1% -$14.3K 0.02% 1010
2014
Q1 		$976K Buy
94,565
+67,103
+244% +$754K 0.02% 1108
2013
Q4 		$267K Buy
27,462
+14,925
+119% +$134K ﹤0.01% 2183
2013
Q3 		$124K Sell
12,537
-597
-5% -$5.86K ﹤0.01% 2828
2013
Q2 		$109K Buy
+13,134
New +$159K ﹤0.01% 2734

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Group One Trading's IRWD Position: Q1 2025 in Review

Group One Trading sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2025, closing a stake of 1,403 shares — an estimated $3.34K sold.

Group One Trading first reported a position in IRWD in Q2 2013 and held it in 26 quarters. The position peaked at $795K in Q1 2014. 200 funds tracked by Wall St. Rank hold IRWD as of Q1 2025.

  • Group One Trading reported no remaining Ironwood Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Group One Trading sold 1,403 Ironwood Pharmaceuticals shares in Q1 2025, an estimated $3.34K.
  • Group One Trading first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 26 quarters.
  • Group One Trading's Ironwood Pharmaceuticals position peaked at $795K in Q1 2014.
  • 200 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2025.

Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.